MARGARET BRENNAN: Those specific racial minorities- minorities are who you're targeting. We know that when it comes to the infections from COVID-19, it is Black and brown America that is disproportionately being hit. (AP Photo/Pablo Martinez Monsivais, File). MARGARET BRERNNAN: So you think you could get the FDA to approve it as safe and distribute it across to Americans before the end of the year?
 The American Academy of Neurology rates it as having unproven efficacy, while the Canadian Headache Society and the European Federation of Neurological Societies rate its use as being supported by moderate and low-quality evidence, respectively. And at the end of the day, it's only money. Now, we feel quite comfortable with the safety of the product. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The Tillis campaign committee eventually cashed checks from CEOs and other high-ranking executives at those companies as well as Amgen, Eli Lilly, Sanofi, and Bristol Myers-Squibb, plus two high-ranking officials at the advocacy group PhRMA. Now we will go to 16 years old. The vaccine also must be proven safe. A number of prominent scientists at the FDA, the agency that will have to say whether your vaccine is safe, also came out with a public letter pledging the same. CEO Albert Bourla told the employees that the company is “moving at the speed of science,” rather than under any political timing, according to a staff letter obtained by The Associated Press. So why do you think that's worth the risk? Pharma sprung into action.
So stay with us. They want to see how we are going to progress, what type of moves you are going to do. MARGARET BRENNAN: And by diversity, I know in your current study, about a quarter of the participants are racial minorities. • MARGARET BRENNAN: One of the companies hard at work on developing a vaccine for COVID-19 is Pfizer, and CEO Albert Bourla joins us now from Westchester, New York. So far, the company has recruited 25,000 patients to test the vaccine, Bourla said. And what is it actually buy you? © 2020 Advance Local Media LLC. So volunteers from all over the country raised their hands to participate. That will not break the company, although it is going to be painful because we are investing one billion and a half at least in COVID right now. NBC anchor Savannah Guthrie asked Bourla about President Trump’s recent comments alluding to having a vaccine before Election Day.